Maho Sato
Izumi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Growth hormone therapy after hematopoietic cell transplantation in childhood: a nationwide survey and longitudinal cohort study.
Journal: Frontiers in endocrinology
Published: March 16, 2026
Transplantation outcomes in patients with Down syndrome-associated acute lymphoblastic leukaemia: Implications for treatment intensity and the use of novel therapies.
Journal: British journal of haematology
Published: January 15, 2026
Retrospective comparison of mesenchymal stromal cells and antithymocyte globulin as second-line therapy for acute graft-versus-host disease.
Journal: Cytotherapy
Published: January 11, 2026
Utility of transplant conditioning intensity score in allogeneic haematopoietic stem cell transplantation for genetic disorders.
Journal: British journal of haematology
Published: October 09, 2025
Impact of Conditioning Regimen Type on Outcomes in Pediatric Patients with De Novo Advanced Myelodysplastic Syndrome Undergoing Hematopoietic Stem Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: September 21, 2025
Effect of Inflammatory Bowel Disease on Clinical Outcomes of Hematopoietic Cell Transplantation for Inborn Errors of Immunity.
Journal: Transplantation and cellular therapy
Published: September 01, 2025
Changes in body mass index during chemotherapy are positively associated with height outcome in childhood cancer survivors of acute lymphoblastic leukemia.
Journal: Endocrine journal
Published: June 26, 2025
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosis.
Journal: International journal of hematology
Published: November 07, 2024
Engraftment outcome of patients with anti-HLA antibodies in HLA-mismatched peripheral blood stem cell transplantation.
Journal: International journal of hematology
Published: July 17, 2024
Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.
Journal: Bone marrow transplantation
Published: June 30, 2024
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Journal: Journal of hematology & oncology
Published: April 01, 2024
Last Updated: 09/26/2026